4 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
Follow Hemolysis: new trials by email Literature Review of Hemolysis trials Research Report on Hemolysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP KZR-616 - Autoimmune Hemolytic Anemia, Immune Thrombocytopenia | Phase 2 | Withdrawn | Kezar Life Sciences, Inc. | 2020-07-01 | 2020-08-07 | |
| Effects of Nitric Oxide on the Endothelium During Hemolysis. Nitric Oxide, Reactive Hyperemia Index, Endothelial Cells Collection - Endothelial Dysfunction, Hemolysis Intravascular | Phase 2 | Withdrawn | Massachusetts General Hospital | 2018-12-05 | 2025-12-02 | |
| A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome Cemdisiran - Atypical Hemolytic Uremic Syndrome | Phase 2 | Withdrawn | Alnylam Pharmaceuticals | 2017-09-19 | 2018-10-01 | |
| Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion Nitric Oxide - Hypertension, Pulmonary, Hemolysis | Phase 2 | Withdrawn | Massachusetts General Hospital | 2016-03-01 | 2016-03-18 |
Thrombocytopenia (2) · Anemia (1) · Anemia, Hemolytic, Autoimmune (1) · Atypical Hemolytic Uremic Syndrome (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hypertension, Pulmonary (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Renal Insufficiency (1) · Thrombotic Microangiopathies (1)
Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Anemia, Hemolytic (2) · Blood Platelet Disorders (2) · Cytopenia (2) · Hemic and Lymphatic Diseases (2) · Anemia (1) · Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Cardiovascular Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hematologic Diseases (1) · Hemolytic-Uremic Syndrome (1) · Hemorrhage (1)
Nitric Oxide (2) · KZR-616 (1)
Massachusetts General Hospital (2) · Alnylam Pharmaceuticals (1) · Kezar Life Sciences, Inc. (1)
United States (3) · Australia (1) · Bosnia and Herzegovina (1) · Canada (1) · Estonia (1) · Georgia (1) · Italy (1) · Latvia (1) · Lithuania (1) · Moldova (1) · North Macedonia (1) · Poland (1) · Russia (1) · Serbia (1) · Sweden (1)
Lorenzo Berra, MD (1) · Nader Najafian, MD (1)